Onconetix, Inc.
ONCO
$0.92
-$0.04-4.12%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 21.50K | 303.60K | 303.70K | 106.50K | 101.60K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 21.50K | 303.60K | 303.70K | 106.50K | 101.60K |
| Cost of Revenue | 23.10K | 55.90K | 34.80K | 36.00K | 55.80K |
| Gross Profit | -1.70K | 247.70K | 268.90K | 70.50K | 45.80K |
| SG&A Expenses | 2.04M | 1.50M | 2.34M | 1.52M | 1.67M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.11M | 1.59M | 2.37M | 1.45M | 1.75M |
| Operating Income | -2.09M | -1.28M | -2.07M | -1.34M | -1.65M |
| Income Before Tax | -4.21M | 5.67M | -8.78M | -2.37M | -8.55M |
| Income Tax Expenses | -- | 500.00 | -- | -- | -- |
| Earnings from Continuing Operations | -4.21M | 5.67M | -8.78M | -2.37M | -8.55M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.21M | 5.67M | -8.78M | -2.37M | -8.55M |
| EBIT | -2.09M | -1.28M | -2.07M | -1.34M | -1.65M |
| EBITDA | -2.09M | -1.28M | -2.07M | -1.34M | -1.65M |
| EPS Basic | -67.06 | 180.74 | -312.49 | -345.47 | -- |
| Normalized Basic EPS | 38.97 | 135.51 | -14.66 | -88.54 | -- |
| EPS Diluted | -67.06 | 180.74 | -312.49 | -345.47 | -- |
| Normalized Diluted EPS | 38.97 | 135.51 | -14.66 | -88.54 | -- |
| Average Basic Shares Outstanding | 62.90K | 31.40K | 28.10K | 11.20K | -- |
| Average Diluted Shares Outstanding | 62.90K | 31.40K | 28.10K | 11.20K | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |